"A Phase II, Open-Label study of Velcade(Bortezomib)for patients with Androgen-Independent Prostate Carcinoma who progressed on or after prior chemotherapy".
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2011
At a glance
- Drugs Bortezomib (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Jun 2011 New trial record